Literature DB >> 28983588

Dipterocarpus obtusifolius attenuates the effects of lipopolysaccharide‑induced inflammatory response in RAW264.7 macrophages.

Ji-Won Park1, Ok-Kyoung Kwon1, Sei-Ryang Oh1, Joongku Lee2, Sangmi Eum3, Samnang Nguon4, Sang Ho Choi5, Piseth Khiev6, Kyung-Seop Ahn1.   

Abstract

Dipterocarpus obtusifolius has been traditionally used as a herbal medicine and is considered to have anticancer properties. The biological activity of D. obtusifolius in inflammation and the underlying mechanisms of its activity remain to be elucidated. The present study investigated the effects of D. obtusifolius methanolic extract (DOME) on lipopolysaccharide (LPS)‑stimulated inflammation in RAW264.7 cells. The effects of DOME on the production of nitric oxide, prostaglandin E2 and pro‑inflammatory cytokines were assessed by ELISA, western blot analysis and reverse transcription‑quantitative polymerase chain reaction. It was demonstrated that expression of inducible nitric oxide synthase, cyclooxygenase‑2, interleukin‑1β and tumor necrosis factor‑α was suppressed by DOME in LPS‑stimulated cells. Furthermore, treatment with DOME suppressed phosphorylation of mitogen activated protein kinase (MAPK) molecules, including extracellular signal‑regulated kinase, c‑Jun N‑terminal kinase and p38 MAPK. Translocation of the nuclear factor‑κB p65 subunit into the nucleus was additionally inhibited by DOME. Phosphorylation of MAPK promoter activity was inhibited by treatment with DOME, PD98059, SB202190 and SP600125. These results demonstrated that DOME inhibits LPS‑induced inflammatory responses. Therefore, DOME may be a potential therapeutic approach for the treatment of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28983588     DOI: 10.3892/mmr.2017.7655

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  1 in total

1.  Role of melatonin as an SIRT1 enhancer in chronic obstructive pulmonary disease induced by cigarette smoke.

Authors:  Na-Rae Shin; Je-Won Ko; Jong-Choon Kim; Gunhyuk Park; Sung-Hwan Kim; Min-Seok Kim; Joong-Sun Kim; In-Sik Shin
Journal:  J Cell Mol Med       Date:  2019-11-25       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.